If health insurers have their way, Medicare for All will be a nonstarter. And they’ve got the lobbying battle lines drawn to prove it—with pharmaceutical companies on their side.

The Hartford Courant reports that insurers, which dominate the state economy in Connecticut, have teamed up not just with the pharmaceutical industry but also with the American Medical Association and the Federation of American Hospitals in a pitched-battle effort to keep “Medicare for All proposals and other Democratic plans to alter the nation’s health care” from becoming reality.